TG THERAPEUTICS INC (TGTX) Stock Balance Sheet
NASDAQ:TGTX • US88322Q1085
Current stock price
32 USD
+0.02 (+0.06%)
Last:
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 399.88M | |||
| Cash Equivalents | 179.89M | 92.93M | 102.30M | 298.89M | 153.56M | |||
| Marketable Securities | 131.11M | 124.58M | 59.37M | 15.88M | 51.99M | |||
| Receivables | 129.19M | 51.09M | 0.00 | 1.39M | N/A | |||
| Inventories | 110.46M | 39.82M | N/A | N/A | N/A | |||
| Other Current Assets | 15.72M | 9.52M | 6.60M | 14.81M | 6.31M | |||
| Total Current Assets | 566.36M | 317.94M | 168.27M | 330.96M | 611.74M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.15M | 9.56M | 10.82M | 11.07M | 11.84M | |||
| Investments And Advances | 808.00K | 0.00 | 12.40M | 35.53M | N/A | |||
| Goodwill | N/A | 799.00K | 799.00K | 799.00K | 799.00K | |||
| Other Non-Current Assets | 3.37M | 1.28M | 1.27M | 1.26M | 1.26M | |||
| Total Non-Current Assets | 11.33M | 11.64M | 25.30M | 48.66M | 13.90M | |||
| TOTAL ASSETS | 577.69M | 329.59M | 193.57M | 379.63M | 625.64M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 975.00K | 23.12M | |||
| Accrued Expenses | 16.34M | 13.62M | 10.01M | 11.60M | 10.13M | |||
| Accounts Payable | 58.30M | 38.47M | 42.02M | 51.29M | 37.01M | |||
| Other Current Liabilities | 16.04M | 1.63M | 1.17M | 1.51M | 17.30M | |||
| Total Current Liabilities | 90.68M | 53.72M | 53.20M | 65.38M | 87.55M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 244.43M | 100.12M | 71.14M | 66.79M | 7.72M | |||
| Other Non-Current Liabilities | 20.22M | 15.25M | 10.65M | 10.30M | 11.02M | |||
| Total Non-Current Liabilities | 264.65M | 115.36M | 81.78M | 77.09M | 18.74M | |||
| TOTAL LIABILITIES | 355.33M | 169.09M | 134.99M | 142.48M | 106.29M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.53B | -1.51B | -1.53B | -1.33B | -980.60M | |||
| Additional Paid In Capital | 1.76B | 1.67B | 1.59B | 1.57B | 1.50B | |||
| Common Shares | 156.00K | 151.00K | 146.00K | 143.00K | 141.00K | |||
| Treasury Stock | -8.99M | -234.00K | -234.00K | -234.00K | -234.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 155.84M | 151.42M | 146.38M | 143.25M | 140.58M | |||
| Tangible Book Value per Share | 1.43 | 1.05 | 0.39 | 1.65 | 3.69 | |||
| Total Shareholders' Equity | 222.36M | 160.50M | 58.59M | 237.15M | 519.35M | |||
| TOTAL LIABILITIES AND EQUITY | 577.69M | 329.59M | 193.57M | 379.63M | 625.64M | |||
| Statistics | ||||||||
| Debt/Equity | 1.10 | 0.62 | 1.21 | 0.28 | 0.01 | |||
| Current Ratio | 6.25 | 5.92 | 3.16 | 5.06 | 6.99 | |||
| Return On Assets (ROA) | 4.05% | 3.84% | -115.62% | -91.70% | -44.66% | |||
| Return On Equity (ROE) | 10.52% | 7.90% | -382.02% | -146.78% | -53.79% | |||
| Return On Invested Capital (ROIC) | 7.87% | 6.83% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 21.76% | 32.30% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 21.76% | 32.75% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.09